Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionMAI Capital Management
Latest Disclosed Ownership223,761 shares
Latest Disclosed Value $ 13,571,111
MAI Capital Management ownership in BRM / Bristol-Myers Squibb Company

On May 15, 2026 - MAI Capital Management filed a 13F-HR form disclosing ownership of 223,761 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $11,729,552 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 198,174 shares of Bristol-Myers Squibb Company. This represents a change in shares of 12.91% during the quarter. The current value of the position is $10,612,984 USD.

MAI Capital Management has a history of taking positions in derivatives of the underlying security (BRM) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:BRM / Bristol-Myers Squibb Company Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 223,761 25,587 12.91 13,571 26.96 0.0766
2026-02-13 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 198,174 21,672 12.28 10,689 34.28 0.0615
2025-11-10 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 176,502 15,703 9.77 7,960 6.95 0.0496
2025-08-12 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 160,799 -8,803 -5.19 7,443 -28.04 0.0514
2025-05-15 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 169,602 -4,262 -2.45 10,344 5.19 0.0780
2025-02-14 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 173,864 57,178 49.00 9,834 62.88 0.0729
2024-11-07 2024-09-30 13F Bristol-Myers Squibb CS 110122108 116,686 -26,254 -18.37 6,037 1.70 0.0575
2024-08-12 2024-06-30 13F Bristol-Myers Squibb CS 110122108 142,940 -466,327 -76.54 5,936 -82.03 0.0582
2024-05-08 2024-03-31 13F Bristol-Myers Squibb CS 110122108 609,267 37,626 6.58 33,041 12.65 0.3423
2024-02-09 2023-12-31 13F Bristol-Myers Squibb CS 110122108 571,641 50,796 9.75 29,331 -2.97 0.3855
2023-11-14 2023-09-30 13F Bristol-Myers Squibb CS 110122108 520,845 -13,983 -2.61 30,230 -11.62 0.4496
2023-08-02 2023-06-30 13F Bristol-Myers Squibb CS 110122108 534,828 1,556 0.29 34,202 -7.46 0.5032
2023-05-10 2023-03-31 13F Bristol-Myers Squibb CS 110122108 533,272 -11,323 -2.08 36,961 -5.67 0.5822
2023-02-09 2022-12-31 13F Bristol-Myers Squibb CS 110122108 544,595 20,373 3.89 39,184 5.14 0.6583
2022-11-15 2022-09-30 13F Bristol-Myers Squibb CS 110122108 524,222 80,861 18.24 37,267 9.16 0.7000
2022-07-19 2022-06-30 13F Bristol-Myers Squibb CS 110122108 443,361 66,461 17.63 34,139 24.03 0.6520
2022-05-10 2022-03-31 13F Bristol-Myers Squibb CS 110122108 376,900 100,915 36.57 27,525 59.95 0.4626
2022-02-11 2021-12-31 13F Bristol-Myers Squibb CS 110122108 275,985 62,972 29.56 17,208 36.53 0.2772
2021-11-12 2021-09-30 13F Bristol-Myers Squibb CS 110122108 213,013 13,931 7.00 12,604 -5.25 0.2427
2021-07-19 2021-06-30 13F Bristol-Myers Squibb CS 110122108 199,082 6,581 3.42 13,303 9.46 0.2641
2021-05-10 2021-03-31 13F Bristol-Myers Squibb CS 110122108 192,501 5,758 3.08 12,153 4.91 0.2716
2021-02-16 2020-12-31 13F Bristol-Myers Squibb CS 110122108 186,743 -160,922 -46.29 11,584 -44.74 0.2897
2020-10-26 2020-09-30 13F Bristol-Myers Squibb CS 110122108 347,665 8,240 2.43 20,961 5.03 0.6068
2020-07-27 2020-06-30 13F Bristol-Myers Squibb CS 110122108 339,425 189,246 126.01 19,958 138.42 0.6265
2020-04-16 2020-03-31 13F Bristol-Myers Squibb CS 110122108 150,179 60,180 66.87 8,371 44.90 0.3416
2020-02-03 2019-12-31 13F Bristol-Myers Squibb CS 110122108 89,999 27,512 44.03 5,777 82.30 0.1872
2019-10-29 2019-09-30 13F Bristol-Myers Squibb CS 110122108 62,487 -18,321 -22.67 3,169 -13.53 0.1412
2019-08-15 2019-06-30 13F Bristol-Myers Squibb CS 110122108 80,808 -58,650 -42.06 3,665 -44.92 0.1656
2019-04-29 2019-03-31 13F Bristol-Myers Squibb CS 110122108 139,458 9,270 7.12 6,654 -1.67 0.3407
2019-01-30 2018-12-31 13F Bristol-Myers Squibb CS 110122108 130,188 5,269 4.22 6,767 -12.74 0.3944
2018-10-12 2018-09-30 13F Bristol-Myers Squibb CS 110122108 124,919 -343 -0.27 7,755 11.87 0.3962
2018-08-16 2018-06-30 13F Bristol-Myers Squibb CS 110122108 125,262 1,180 0.95 6,932 -11.67 0.3739
2018-04-17 2018-03-31 13F Bristol-Myers Squibb CS 110122108 124,082 900 0.73 7,848 3.96 0.4456
2018-01-30 2017-12-31 13F Bristol-Myers Squibb CS 110122108 123,182 -6,986 -5.37 7,549 -9.02 0.4289
2017-10-12 2017-09-30 13F Bristol-Myers Squibb CS 110122108 130,168 -1,524 -1.16 8,297 13.07 0.5037
2017-08-07 2017-06-30 13F Bristol-Myers Squibb CS 110122108 131,692 9,035 7.37 7,338 10.01 0.4727
2017-05-11 2017-03-31 13F Bristol-Myers Squibb CS 110122108 122,657 114,533 1,409.81 6,670 1,304.21 0.4488
2017-01-31 2016-12-31 13F Bristol-Myers Squibb CS 110122108 8,124 -1,001 -10.97 475 -3.46 0.0345
2016-10-18 2016-09-30 13F Bristol-Myers Squibb CS 110122108 9,125 -9,123 -49.99 492 -63.34 0.0371
2016-07-14 2016-06-30 13F Bristol-Myers Squibb CS 110122108 18,248 -884 -4.62 1,342 9.82 0.1034
2016-04-08 2016-03-31 13F Bristol-Myers Squibb CS 110122108 19,132 -106 -0.55 1,222 -7.63 0.0935
2016-01-27 2015-12-31 13F Bristol-Myers Squibb CS 110122108 19,238 734 3.97 1,323 20.82 0.1009
2015-10-28 2015-09-30 13F Bristol-Myers Squibb CS 110122108 18,504 314 1.73 1,095 -9.50 0.0828
2015-07-09 2015-06-30 13F Bristol-Myers Squibb CS 110122108 18,190 941 5.46 1,210 8.72 0.0797
2015-04-30 2015-03-31 13F Bristol-Myers Squibb CS 110122108 17,249 3,728 27.57 1,113 39.47 0.0746
2015-01-20 2014-12-31 13F Bristol-Myers Squibb CS 110122108 13,521 2,806 26.19 798 45.62 0.0560
2014-10-16 2014-09-30 13F/A-1 Bristol-Myers Squibb CS 110122108 10,715 -2,250 -17.35 548 -12.88 0.0528
2014-10-16 2014-09-30 13F Bristol-Myers Squibb COM 110122108 12,965 629
2014-07-28 2014-06-30 13F Bristol-Myers Squibb COM 110122108 12,965 -4,615 -26.25 629 -31.11 0.0604
2014-04-28 2014-03-31 13F Bristol-Myers Squibb COM 110122108 17,580 -57 -0.32 913 -2.56 0.0919
2014-02-06 2013-12-31 13F Bristol-Myers Squibb COM 110122108 17,637 -1,315 -6.94 937 6.84 0.0993
2013-10-28 2013-09-30 13F Bristol-Myers Squibb COM 110122108 18,952 -435 -2.24 877 1.27 0.1140
2013-08-01 2013-06-30 13F Bristol-Myers Squibb COM 110122108 19,387 19,387 866 0.1129
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-05-10 2022-03-31 13F Bristol-Myers Squibb CS Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-11 2021-12-31 13F Bristol-Myers Squibb CS Call 600 37 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.